Clinical Trial Update: AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer

View source ↗

Summary

Clinical trial examining whether AREG, EREG, and EGFR influence response to anti-EGFR therapy in colorectal cancer. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University of Leeds | Conditions: Colorectal Cancer Stage IV | Status: COMPLETED